[Endoscopic transpapillary methods of choledocholithiasis treatment, caused by presence of multiple calculi].
The results of endoscopic transpapillary surgical interventions in 115 patients, suffering choledocholithiasis, caused by the multiple calculi presence, were analyzed. The patients were divided on four groups, depending on the treatment provided. In 78 patients (first group) endoscopic papillosphincterotomy with mechanical lithoextraction in conjunction with spasmolytic and infusion therapy were performed. In 16 patients (second group) endoscopic papillosphincterotomy with mechanical lithotripsy and partial lithoextraction, endobiliary stenting with further spasmolytic and infusion therapy were performed. In 11 patients (the third group) endoscopic papillosphincterotomy, mechanical lithotripsy with a partial lithoextraction and nasobiliary drainage were used. In 10 patients (the fourth group) endoscopic papillosphincterotomy, mechanical lithotripsy, nasobiliary drainage and endobiliary stenting were applied. The best results were achieved in the first group: the smallest duration of the operation--(32.2 +/- 12.6) min, the smallest stationary state duration--(3.3 +/- 1.2) days, the lowest rate of intraoperative complications--2.6%.
P V
PV
Ohorodnik
A G
AG
Deĭnichenko
D I
DI
Khrystiuk
O H
OH
Boĭko
D000328:Adult; D000368:Aged; D042883:Choledocholithiasis / Q000473:pathology / Q000601:surgery* / Q000628:therapy; D003135:Common Bile Duct / Q000473:pathology / Q000601:surgery*; D004322:Drainage; D004384:Duodenoscopy / Q000009:adverse effects / Q000379:methods*; D005260:Female; D005440:Fluid Therapy; D042882:Gallstones / Q000473:pathology / Q000601:surgery* / Q000628:therapy; D006801:Humans; D007431:Intraoperative Complications / Q000473:pathology / Q000517:prevention & control; D007441:Intubation, Gastrointestinal; D008096:Lithotripsy / Q000379:methods; D008297:Male; D008875:Middle Aged; D010276:Parasympatholytics / Q000008:administration & dosage / Q000627:therapeutic use; D016717:Sphincterotomy, Endoscopic / Q000009:adverse effects / Q000379:methods; D015607:Stents
D010276:Parasympatholytics